CVE-2026-24217: NVIDIA BioNeMo Framework · Path Traversal: '\..\filename
Affects NVIDIA BioNeMo FrameworkSource CVE Database V5
Not known to be exploited · CVSS 8.8 High : upgrade to commit dfd83a7 on main soon.
Data as of 30 Oct 2026, 11:52 UTC
- EPSS
- 0.7% chance of exploitation in 30 days – higher than 55% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
- Patch
- Available – fixed in commit dfd83a7 on main
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:HExploitation evidence
Disclosed: evidence found.
CVE published 20 May 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 30 Oct 2026.
What to do
Upgrade NVIDIA BioNeMo Framework to commit dfd83a7 on main.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| NVIDIABioNeMo Framework | Affected
| Fixed in
|
AI-suggested
If you cannot patch yet, users should exercise caution when loading files in the BioNeMo Framework and restrict access to trusted sources only.
Description
NVIDIA BioNeMo Core for Linux has a path traversal vulnerability (CWE-29) that allows a user to load a malicious file using a crafted path such as '\.. \filename'. Exploiting this vulnerability could lead to code execution, denial of service, information disclosure, and data tampering. The vulnerability has a high severity with a CVSS score of 8.8. There are no known exploits in the wild at this time.